CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy

BACKGROUND: Locally advanced breast cancer often undergoes neoadjuvant chemotherapy (NAC), which allows in vivo evaluation of the therapeutic response. The determination of the pathological complete response (pCR) is one way to evaluate the response to neoadjuvant chemotherapy. However, the rate of...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMC Cancer
Prif Awduron: Alves, Wilson Eduardo Furlan Matos, Bonatelli, Murilo, Dufloth, Rozany, Kerr, Lígia Maria, Carrara, Guilherme Freire Angotti, da Costa, Ricardo Filipe Alves, Scapulatempo-Neto, Cristovam, Tiezzi, Daniel, da Costa Vieira, René Aloísio, Pinheiro, Céline
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2019
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6889185/
https://ncbi.nlm.nih.gov/pubmed/31795962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6353-2
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg